GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,111,000 | +38.1% | 860,103 | 0.0% | 0.30% | +9.3% |
| Q1 2020 | $2,976,000 | -58.3% | 860,103 | -11.5% | 0.27% | -59.6% |
| Q2 2019 | $7,139,000 | -10.0% | 971,337 | 0.0% | 0.67% | -15.4% |
| Q1 2019 | $7,936,000 | +19.6% | 971,337 | 0.0% | 0.79% | -6.6% |
| Q4 2018 | $6,634,000 | -42.6% | 971,337 | +14.1% | 0.85% | -27.3% |
| Q3 2018 | $11,563,000 | +22.6% | 851,492 | +7.4% | 1.16% | -4.1% |
| Q2 2018 | $9,433,000 | – | 792,707 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,832,484 | $13,469,000 | 1.47% |
| Knoll Capital Management, LLC | 206,099 | $1,515,000 | 1.24% |
| 683 Capital Management, LLC | 1,350,000 | $9,923,000 | 0.90% |
| Vivo Capital, LLC | 971,337 | $7,139,000 | 0.67% |
| P.A.W. CAPITAL CORP | 70,000 | $515,000 | 0.56% |
| Ibex Investors LLC | 807,400 | $5,934,000 | 0.48% |
| MEITAV INVESTMENT HOUSE LTD | 639,269 | $4,693,000 | 0.31% |
| Nantahala Capital Management | 879,200 | $6,559,000 | 0.20% |
| Rock Creek Group, LP | 57,201 | $420,000 | 0.19% |
| FIRST MIDWEST BANK TRUST DIVISION | 164,847 | $1,212,000 | 0.17% |